Annual Total Long Term Liabilities
$0.00
-$39.71 M-100.00%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual total long term liabilities is $0.00, with the most recent change of -$39.71 million (-100.00%) on December 31, 2023.
- During the last 3 years, EIGR annual total long term liabilities has fallen by -$31.93 million (-100.00%).
- EIGR annual total long term liabilities is now -100.00% below its all-time high of $56.28 million, reached on December 1, 2011.
Performance
EIGR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
-$40.73 M-100.00%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly total long term liabilities is $0.00, with the most recent change of -$40.73 million (-100.00%) on December 31, 2023.
- Over the past year, EIGR quarterly long term liabilities has dropped by -$39.71 million (-100.00%).
- EIGR quarterly long term liabilities is now -100.00% below its all-time high of $40.73 million, reached on September 30, 2023.
Performance
EIGR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
EIGR Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | -100.0% |
| 3 y3 years | -100.0% | -100.0% |
| 5 y5 years | -100.0% | -100.0% |
EIGR Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
Eiger BioPharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2023 | - | $40.73 M(+1.0%) |
| Jun 2023 | - | $40.35 M(+0.9%) |
| Mar 2023 | - | $39.99 M(+0.7%) |
| Dec 2022 | $39.71 M(+64.7%) | $39.71 M(+1.0%) |
| Sep 2022 | - | $39.32 M(+1.0%) |
| Jun 2022 | - | $38.92 M(+100.1%) |
| Mar 2022 | - | $19.45 M(-19.3%) |
| Dec 2021 | $24.10 M(-24.5%) | $24.10 M(-16.3%) |
| Sep 2021 | - | $28.80 M(-9.5%) |
| Jun 2021 | - | $31.84 M(+0.1%) |
| Mar 2021 | - | $31.81 M(-0.4%) |
| Dec 2020 | $31.93 M(+0.7%) | $31.93 M(+22.4%) |
| Sep 2020 | - | $26.08 M(-8.5%) |
| Jun 2020 | - | $28.52 M(-10.2%) |
| Mar 2020 | - | $31.77 M(+0.2%) |
| Dec 2019 | $31.71 M(+22.8%) | $31.71 M(+0.4%) |
| Sep 2019 | - | $31.59 M(+0.2%) |
| Jun 2019 | - | $31.53 M(+0.2%) |
| Mar 2019 | - | $31.48 M(+21.8%) |
| Dec 2018 | $25.83 M | $25.83 M(+35.5%) |
| Sep 2018 | - | $19.07 M(+10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $17.23 M(+43.7%) |
| Mar 2018 | - | $11.99 M(-8.4%) |
| Dec 2017 | $13.09 M(-11.1%) | $13.09 M(-12.7%) |
| Sep 2017 | - | $14.99 M(+0.6%) |
| Jun 2017 | - | $14.90 M(+0.7%) |
| Mar 2017 | - | $14.80 M(+0.5%) |
| Dec 2016 | $14.73 M(>+9900.0%) | $14.73 M(>+9900.0%) |
| Sep 2016 | - | $15.00 K(0.0%) |
| Jun 2016 | - | $15.00 K(0.0%) |
| Mar 2016 | - | $15.00 K(-37.5%) |
| Dec 2015 | $24.00 K(-99.8%) | $24.00 K(-17.2%) |
| Sep 2015 | - | $29.00 K(-90.1%) |
| Jun 2015 | - | $293.00 K(-96.7%) |
| Mar 2015 | - | $9.00 M(-13.5%) |
| Dec 2014 | $10.40 M(+89.5%) | $10.40 M(+3.8%) |
| Sep 2014 | - | $10.02 M(>+9900.0%) |
| Jun 2014 | - | $46.00 K(+31.4%) |
| Mar 2014 | - | $35.00 K(-99.4%) |
| Dec 2013 | $5.49 M(-46.7%) | $5.49 M(>+9900.0%) |
| Sep 2013 | - | $40.00 K(-99.3%) |
| Jun 2013 | - | $5.49 M |
| Dec 2012 | $10.29 M(-81.7%) | - |
| Dec 2011 | $56.28 M | - |
FAQ
- What is Eiger BioPharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual total long term liabilities year-on-year change?
- What is Eiger BioPharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly long term liabilities year-on-year change?
What is Eiger BioPharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of EIGR is $0.00
What is the all time high annual total long term liabilities for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual total long term liabilities is $56.28 M
What is Eiger BioPharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, EIGR annual total long term liabilities has changed by -$39.71 M (-100.00%)
What is Eiger BioPharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of EIGR is $0.00
What is the all time high quarterly long term liabilities for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly total long term liabilities is $40.73 M
What is Eiger BioPharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, EIGR quarterly total long term liabilities has changed by -$39.71 M (-100.00%)